Who is sponsoring NCT03432481?

NCT03432481 is sponsored by Laboratoires Bodycad Inc..

What drugs are being tested in NCT03432481?

Interventions in NCT03432481: Unicompartmental Knee Arthroplasty Surgery, Bodycad Unicompartmental Knee System (BUKS).

What condition does NCT03432481 study?

NCT03432481 studies Osteoarthritis, Knee.

Is NCT03432481 still recruiting?

NCT03432481 is currently terminated. Last updated 25 August 2023.

Last reviewed 2023-08-25 · How we verify

NCT03432481

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Investigational Testing of Bodycad Unicompartmental Knee Prosthesis (UKS)

Terminated NA Last updated 25 August 2023

What this trial tests

NA trial testing Unicompartmental Knee Arthroplasty Surgery in Osteoarthritis, Knee in 28 participants. Terminated before completion.

Timeline

24 January 2018

Primary endpoint
20 August 2020

7 March 2023

Quick facts

Lead sponsor	Laboratoires Bodycad Inc.
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	28
Start date	24 January 2018
Primary completion	20 August 2020
Estimated completion	7 March 2023
Sites	1 location across Canada

Drugs / interventions tested

Unicompartmental Knee Arthroplasty Surgery
Bodycad Unicompartmental Knee System (BUKS)

Conditions studied

Osteoarthritis, Knee — all drugs for Osteoarthritis, Knee →

Sponsor

Laboratoires Bodycad Inc.

Who can join

Adults 45 to 70, any sex, with Osteoarthritis, Knee. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is designed to observe clinical outcomes of patient-specific knee arthroplasty in patients with osteoarthritis of the medial condyle.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Osteoarthritis, Knee

Currently open trials in the same condition.

NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
NCT06488144 — Rehabilitation for Arthritis of The Knee: mainTaining Improvement for Veterans · Phase 3 · recruiting
NCT07386561 — Virtual Reality Therapy and Non-Sleep Deep Rest Relaxation After Joint Arthroplasty · NA · active not recruiting
NCT07514598 — Effect of J-Shaped Incision After Total Knee Arthroplasty (J-TKA) · NA · active not recruiting
NCT07058623 — Nurse-Led Telehealth vs In-Person Follow-Up After Total Knee Replacement · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03432481 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Laboratoires Bodycad Inc.
Last refreshed: 25 August 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03432481.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing